Jia Luo, MD
@Jia_Luo
Followers
970
Following
1K
Media
302
Statuses
924
@DanaFarber @harvardmed thoracic medical oncologist and cancer researcher // Prev MSKCC Fellow, OHSU IM & Chief Res, Stanford Med, and UW-Madison #GlobalCook
Boston, MA
Joined May 2011
RT @OncLive: Thank you to @Jia_Luo of @DanaFarber for sharing updates at #AACR25 on early ctDNA reduction with daraxonrasib in RAS-mutant N….
0
1
0
RT @DanaFarberNews: KRAS research at #AACR25: Study of next-gen KRAS G12C inhibitor divarasib plus SHP2 inhibition showed activity in treat….
0
3
0
RT @DanaFarberNews: At #AACR25, @Jia_Luo, MD, @DanaFarber presents a late-breaking abstract on the clinical activity of daraxonrasib in KRA….
0
7
0
RT @OncLive: ✨EXCLUSIVE PREVIEW✨: Ahead of #AACR25, we asked leading oncologists which abstracts they’re looking forward to. @HardingJJMD….
0
3
0
RT @MSKLibrary: Featured today by @MSKLibrary: Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment….
0
1
0
RT @jennifermarksmd: Dr. @Jia_Luo reviews and emphasizes when to suspicious that your patient may have a #NUT carcinomas. We need to ensure….
0
6
0
RT @NarjustFlorezMD: WHAT A WONDERFUL DISCUSSION! . Discussing NUT Carcinoma and Mesothelioma with these amazing ladies Dr. @MMarmarelis an….
0
4
0
RT @IASLC: 🎙️ LIVE from #TTLC25! @NarjustFlorezMD @Jia_Luo & Dr. Melina Marmarelis discuss two of the most challenging thoracic malignancie….
0
8
0
RT @DFarberThoracic: DFCI Thoracic Oncology Team at #TTLC25! @IASLC @JuliaRotow @sands_jacob @Jia_Luo @NarjustFlorezMD @DavidBarbie8 https….
0
5
0
RT @HHorinouchi: 🔥 @NatRevClinOncol 🆙.✅Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lu….
nature.com
Nature Reviews Clinical Oncology - Accumulating evidence indicates that NUT carcinoma, a highly aggressive malignancy driven by NUTM1 fusions, is a rare form of squamous cell carcinoma (SCC) of the...
0
8
0
RT @newsincancer: Lung adenocarcinomas with #mucinous histology: clinical, genomic, and immune microenvironment characterization and outcom….
annalsofoncology.org
Approximately 10% of lung adenocarcinomas (LUADs) have mucinous histology (LUADMuc), which is associated with a light/absent smoking history and a high prevalence of KRAS mutations. We sought to...
0
1
0
RT @NatRevClinOncol: New online! Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs an….
nature.com
Nature Reviews Clinical Oncology - Accumulating evidence indicates that NUT carcinoma, a highly aggressive malignancy driven by NUTM1 fusions, is a rare form of squamous cell carcinoma (SCC) of the...
0
6
0
Hiring 🌟 Associate Director 🌟 @ DFCI Center for RAS Therapeutics/ Office of Strategic Partnerships. Join a group of brilliant, internationally known investigators who inspire me daily & work @ the cutting edge of drug development. #lcsm #MedTwitter.
.@DanaFarber announced the Center for RAS Therapeutics, an initiative that aims to advance new treatments for patients with RAS-mutant cancers through collaborations between researchers, industry, and other academic medical centers. ➡️
0
9
24
RT @DanaFarber: We’re thrilled to announce the launch of Center for RAS Therapeutics to target the RAS oncogene in cancer. The first of its….
0
52
0
RT @QuantumOnc: A very important slide by @Jia_Luo: Biomarkers are the future, and early detection is the key to transforming outcomes. #Pr….
0
1
0
Acknowledgements to the 🌟 team at.@DFarberThoracic @BrighamWomens .Drs French, Shapiro, Hanna, DuBois, Sholl, Barbie, Jänne, & collab Chaft, Paik, Piha-Paul, Hsu, & our patients and funding sources.
0
0
3
Fantastic to have✨@jjustinjkim (MD-to-be) and Sara Walton (first poster!)✨present at the 2024 DF/HCC Lung Cancer Program Symposium. Ty to the organizing committee for selecting their abstracts
1
3
15
RT @jennifermarksmd: Dr. @NIVokes at @MDAndersonNews emphasizes PD-L1 is not a biomarker for IO-IO (CTLA4) response. CCND1, CDK4, and cell….
0
4
0
A close friend, Dr Roxana Daneshjou’s story has been on my mind ever since she shared it with me. ❤️‍🩹. Her courage should inspire all of us to be the change and vote!!.
I hate having to share this, but I know I’m not alone. I had a miscarriage post-Roe while visiting family in Texas in 2022. I almost died — after 7-8 hours of begging, I got an emergency D&C and transfusion. They don’t mind letting women die.
0
0
8